OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Q: What does CUSIP 68277Q105 represent in this 13F holders report?

CUSIP 68277Q105 is the security identifier for OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share in Q2 2026?

75 institutional investors reported OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 68277Q105

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Class A Common Stock, par value $0.0001 per share
Total 13F shares: 34,865,728
Total 13F value: $158,986,605
Share change: +7,325,150
SEC-reported price per share: $4.56
Number of holders: 75
Value change: +$34,178,503
Number of buys: 52
Number of sells: 17
Shares outstanding: 40,703,345

Security key

68277Q105

Report period

Q2 2026

Institutions

Top holders

OKUR full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 OnKure Therapeutics, Inc. SEC filings OnKure Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 68277Q105

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

AI Biotechnology LLC

Disclosed value leader

AI Biotechnology LLC

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 20% 13D/G row: AI Biotechnology LLC Showing 1-6 of 15 holder rows.

Quick read

AI Biotechnology LLC leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AI Biotechnology LLC's linked filing trail.

Comparable ownership Top 5

AI Biotechnology LLC 20%

RA CAPITAL MANAGEMENT, L.P. 9.9%

ACORN BIOVENTURES, L.P. 9.5%

BIOTECHNOLOGY VALUE FUND L P 8%

StepStone Group LP 6.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
AI Biotechnology LLC	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	20%	$24,001,644 9,091,532 shares	$0	31 Mar 2026
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G Company 13F 13D/G	9.9% from 13D/G	$16,553,099 3,998,333 shares	—	31 Mar 2026
ACORN BIOVENTURES, L.P.	3/4/5 13D/G 10%+ Owner · Anders Hove 3/4/5 13D/G	9.5% from 13D/G	$9,098,765 4,279,348 shares mixed-class rows	—	15 May 2025
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	8%	$14,755,148 3,235,778 shares	+$5,019,967	30 Jun 2026
StepStone Group LP	13F 13D/G Company 13F 13D/G	6.6% from 13D/G	$11,014,934 2,660,612 shares	—	31 Mar 2026
Shay Capital LLC	13D/G 13F Company 13D/G 13F	6.3%	$2,057,944 810,214 shares	$0	15 May 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

34,865,728

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend